Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction
Circulation: Genomic and Precision Medicine · 2024-06 · 17 (3)
DOI: 10.1161/circgen.123.004374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024-06. Verfasst von Irene V van Blokland und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (I.V.B., H.E.G., J.W.B.), University Medical Center Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Single-Cell Analysis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: The immune system’s role in ST-segment–elevated myocardial infarction (STEMI) remains poorly characterized but is an important driver of recurrent cardiovascular events. While anti-inflammatory drugs show promise in reducing recurrence risk, their broad immune system impairment may induce severe side effects. To overcome these challenges, a nuanced understanding of the immune response to STEMI is needed. METHODS: For this, we compared peripheral blood mononuclear single-cell RNA-sequencing (scRNA-seq) and plasma protein expression over time (hospital admission, 24 hours, and 6–8 weeks post-STEMI) in 38 patients and 38 controls (95 995 diseased and 33 878 control peripheral blood mononuclear cells). RESULTS: Compared with controls, classical monocytes were increased and CD56 dim natural killer cells were decreased in patients with STEMI at admission and persisted until 24 hours post-STEMI. The largest gene expression changes were observed in monocytes, associating with changes in toll-like receptor, interferon, and interleukin signaling activity. Finally, a targeted cardiovascular biomarker panel revealed expression changes in 33/92 plasma proteins post-STEMI. Interestingly, interleukin-6R, MMP9 (matrix metalloproteinase-9), and LDLR (low-density lipoprotein receptor) were affected by coronary artery disease–associated genetic risk variation, disease status, and time post-STEMI, indicating the importance of considering these aspects when defining potential future therapies. CONCLUSIONS: Our analyses revealed the immunologic pathways disturbed by STEMI, specifying affected cell types and disease stages. Additionally, we provide insights into patients expected to benefit most from anti-inflammatory treatments by identifying the genetic variants and disease stage at which these variants affect the outcome of these (drug-targeted) pathways. These findings advance our knowledge of the immune response post-STEMI and provide guidance for future therapeutic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology (I.V.B., H.E.G., J.W.B.), University Medical Center Groningen, Groningen, the Netherlands.
- Department of Genetics (I.V.B., R.O., L.F., M.G.P.v.d.W.), University Medical Center Groningen, Groningen, the Netherlands.
- Medizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany (K.P., V.K., L.N., K.S.).
- German Center for Cardiovascular Research, Munich Heart Alliance, Munich, Germany (K.P., V.K., L.N., K.S.).
- Institute of Computational Biology, German Research Center for Environmental Health, Helmholtz Zentrum München, Neuherberg, Germany (C.L., M.H.).
- Department of Computer Science, TUM School of Computation, Information & Technology, Garching, Germany (C.L., M.H.).
ORCID-Profile: Irene V van Blokland, Hilde E Groot, Jan Walter Benjamins, Kami Pekayvaz, Matthias Heinig, Leo Nicolai, Pim van der Harst, Lude Franke, Monique G P van der Wijst
Zitieren
APA
van Blokland, I. V., Oelen, R., Groot, H. E., Benjamins, J. W., Pekayvaz, K., Losert, C., Knottenberg, V., Heinig, M., Nicolai, L., Stark, K., van der Harst, P., Franke, L., & van der Wijst, M. G. P. (2024). Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction. Circulation: Genomic and Precision Medicine, 17(3). https://doi.org/10.1161/circgen.123.004374
Vancouver
van Blokland IV, Oelen R, Groot HE, Benjamins JW, Pekayvaz K, Losert C, et al. Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction. Circulation: Genomic and Precision Medicine. 2024;17(3). doi:10.1161/circgen.123.004374
BibTeX
@article{vanBlokland2024,
author = {van Blokland, Irene V and Oelen, Roy and Groot, Hilde E and Benjamins, Jan Walter and Pekayvaz, Kami and Losert, Corinna and Knottenberg, Viktoria and Heinig, Matthias and Nicolai, Leo and Stark, Konstantin and van der Harst, Pim and Franke, Lude and van der Wijst, Monique G P},
title = {Single-Cell Dissection of the Immune Response After Acute Myocardial Infarction},
journal = {Circulation: Genomic and Precision Medicine},
year = {2024},
volume = {17},
number = {3},
doi = {10.1161/circgen.123.004374}
}
EUVIMED